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Somepeople aremorewilling tomake immediate, risky, or costly reward-focused choices than others, which has been hypothesized to be
associated with individual differences in dopamine (DA) function. In two studies using PET imaging, one empirical (Study 1: N 144
males and females across 3 samples) and onemeta-analytic (Study 2:N 307 across 12 samples), we sought to characterize associations
between individual differences in DA and time, probability, and physical effort discounting in human adults. Study 1 demonstrated that
individual differences in DA D2-like receptors were not associated with time or probability discounting of monetary rewards in healthy
humans, and associations with physical effort discounting were inconsistent across adults of different ages. Meta-analytic results for
temporal discounting corroborated our empirical finding for minimal effect of DA measures on discounting in healthy individuals but
suggested that associations between individual differences in DA and reward discounting depend on clinical features. Addictions were
characterized by negative correlations between DA and discounting, but other clinical conditions, such as Parkinson’s disease, obesity,
and attention-deficit/hyperactivity disorder, were characterized by positive correlations between DA and discounting. Together, the
results suggest that trait differences in discounting in healthy adults do not appear to be strongly associated with individual differences
in D2-like receptors. The difference in meta-analytic correlation effects between healthy controls and individuals with psychopathology
suggests that individual difference findings related to DA and reward discounting in clinical samples may not be reliably generalized to
healthy controls, and vice versa.
Key words: decision making; delay discounting; dopamine; effort; PET; probability
Introduction
Discounting is a natural phenomenon that describes the ten-
dency to devalue rewards that are relatively delayed, uncertain, or
require more effort than sooner, more certain, or less effortful
ones. Individual differences in discounting in humans have been
hypothesized to be strongly related to individual differences in
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Significance Statement
Decisions to forgo large rewards for smaller ones due to increasing time delays, uncertainty, or physical effort have been linked to
differences in dopamine (DA) function, which is disrupted in some forms of psychopathology. It remains unclear whether alter-
ations in DA function associated with psychopathology also extend to explaining associations between DA function and decision
making in healthy individuals. We show that individual differences in DA D2 receptor availability are not consistently related to
monetary discounting of time, probability, or physical effort in healthy individuals across a broad age range. By contrast, we
suggest that psychopathology accounts for observed inconsistencies in the relationship between measures of DA function and
reward discounting behavior.
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dopamine (DA) function. Studies of human and nonhuman an-
imals have reported that pharmacological effects on DA D2-like
receptors (D2Rs) alter discounting (Salamone et al., 1996; St
Onge et al., 2010; Koffarnus et al., 2011; Weber et al., 2016).
Specifically, D2Rs are believed to regulate decisions to inhibit
impulsive actions (Frank, 2005; Ghahremani et al., 2012; Robert-
son et al., 2015), such as choosing smaller-sooner/more-likely/
less-effortful rewards. However, studies of the transient manipu-
lation of theDA systemdo not clarify whethermore persistent indi-
vidual differences in decisionmaking are also primarilymediated by
differences in DAD2R expression.
Multiple studies have reported links betweendiscounting behav-
ior and forms of psychopathology that are associatedwith alteration
in striatal DA function, including the following: drug addiction
(MacKillop et al., 2011; Amlung et al., 2017), obesity (Amlung et al.,
2016), schizophrenia and bipolar disorder (Ahn et al., 2011), atten-
tion-deficit/hyperactivity disorder (ADHD) (Amlung et al., 2016),
andParkinson’s disease (PD) (Kaasinen andVahlberg, 2017).While
these studies suggest a common involvement of DA in discounting
indisease, it leavesopenquestionsabout specific features andclinical
range of influence between DA and discounting behavior.
Only a few studies have directly assessed associations between
trait-like individual differences in DA function and discounting
behavior. Several recent studies using PET suggest that reduced
availability of DA receptors contributes to greater discounting
(for a summary of DA PET studies of reward discounting, see
Table 1). However, many existing studies are limited by small
sample sizes (Button et al., 2013), a focus on only temporal dis-
counting (Crunelle et al., 2014; Ballard et al., 2015; Cho et al.,
2015; Joutsa et al., 2015; Oberlin et al., 2015; Smith et al., 2016) or
a mixture of decision features which may or may not be disso-
ciable (Treadway et al., 2012), use of radiotracers with limited
visibility outside the striatum (e.g., [11C]raclopride), or assess-
ment of individuals with psychopathology (that vary in DA and
other neuromodulatory functions) (Crunelle et al., 2014; Ballard
et al., 2015; Eisenstein et al., 2015; Joutsa et al., 2015; Oberlin et
al., 2015). Although prior PET studies have largely focused on the
striatum, DA neurons in the midbrain also project to the
amygdala, hippocampus, thalamus, anterior cingulate, insula,
and frontal and parietal lobes (Bjo¨rklund et al., 1978; Berger et al.,
1991). Accordingly, there may be subtle differences in how DA
function uniquely accounts for different types of discounting
across the brain in individuals who vary in DA status.
It remains unclear whether there exists a reliable association
between individual differences in DA and discounting in healthy
humans. Here, in two studies (one empirical and one meta-
analytic), we sought to characterize the relationship between in-
dividual differences in DA and decision making in healthy
human adults. In Study 1, we analyzed data from three samples of
healthy adults (young adults,N 25, and adult life-span,N 84,
N 35). We estimated time, probability, and effort discounting
of monetary rewards using multiple tasks that attempted to dis-
sociate discounting of these three decision features and estimated
DAD2R availability using PET imaging with two different radio-
tracers, [18F]fallypride and [11C]FLB 457, with complementary
coverage of striatal and extrastriatal brain regions (Cropley et al.,
2006). We analyzed data from multiple samples across a broad
age range to examine the generality of effects across human
adults. In Study 2, we performed a quantitative meta-analysis to
examine the consistency of or variation in individual differences
across PET imaging studies of DA and discounting in healthy
human adults and clinical groups.
Materials andMethods
Study 1
Participants and procedures. The data analyzed here were collected from
three different samples at two different universities. They will be de-
scribed as Samples 1–3. Sample 1 included 25 healthy young adults (ages
18–24 years; mean SD, 20.9 1.83 years; 13 females) recruited from
the Vanderbilt University community in Nashville, TN between 2012
and 2013. Sample 2 included 84 healthy adults (ages 22–83 years;
mean  SD, 49.4  17.6 years; 48 females) recruited from the Greater
Nashville, TN metropolitan area between 2013 and 2016. Sample 3 in-
cluded 35 healthy adults (ages 26–79 years; mean  SD, 47.7  17.4
years; 30 females) recruited from the Greater NewHaven, CTmetropol-
itan area between 2015 and 2017. Data from Samples 1 and 2 were col-
lected at Vanderbilt University, and data from Sample 3 were collected at
Yale University (for descriptive statistics for each sample, see Table 2).
Screening criteria. Across samples, participants were subject to the fol-
lowing exclusion criteria: any history of psychiatric illness on a screening
interview (a Structural Interview for Clinical DSM-IVDiagnosis was also
available for all subjects and confirmed no history of major Axis I disor-
ders) (First et al., 1997), any history of head trauma, any significant
medical condition, or any condition that would interfere withMRI (e.g.,
inability to fit in the scanner, claustrophobia, cochlear implant, metal
fragments in eyes, cardiac pacemaker, neural stimulator, pregnancy, and
metallic body inclusions or other contraindicatedmetal implanted in the
body). Participants with major medical disorders, including diabetes,
and/or abnormalities on a comprehensive metabolic panel, complete
blood count, or EKG, were excluded. Participants were also excluded if
they reported a history of substance abuse, current tobacco use, alcohol
consumption8 ounces of whiskey or equivalent per week, use of psy-
chostimulants (excluding caffeine) more than twice at any time in their
life or at all in the past 6 months, or any psychotropic medication in the
last 6months other than occasional use of benzodiazepines for sleep. Any
illicit drug use in the last 2 months was grounds for exclusion, even in
participants who did not otherwise meet criteria for substance abuse.
Urine drug tests were administered, and subjects testing positive for the
presence of amphetamines, cocaine, marijuana, PCP, opiates, benzodi-
azepines, or barbiturates were excluded. Premenopausal females had
negative pregnancy tests at intake and on the day of the scan. There were
minor differences in exclusion thresholds between Samples 1/2 and Sam-
ple 3 based on the location and full study protocol (e.g., a subset of
subjects in Sample 3 also received an oral dose of D-amphetamine). For
full screening details, see Smith et al. (2017).
PET imaging: [18F]fallypride data acquisition and preprocessing (Sam-
ples 1 and 2). [18F]Fallypride, (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-
(3[18F]fluoropropyl)-2,3-dimethoxybenzamide was produced in the
radiochemistry laboratory attached to the PET unit at Vanderbilt Uni-
versity Medical Center, following synthesis and quality control proce-
dures described byU.S. Food andDrugAdministration IND47,245. PET
datawere collected on aGEDiscovery STEPET scanner (GEHealthcare).
Serial scan acquisition was started simultaneously with a 5.0 mCi (185
MBq; Study 1 median specific activity 5.33 mCi, SD 0.111; Study 2
median specific activity 5.32, SD 0.264) slow bolus injection of DA
D2/3 tracer [18F]fallypride (specific activity3000 Ci/mmol). CT scans
were collected for attenuation correction before each of the three emis-
sion scans, which together lasted 3.5 h with two breaks for subject
comfort. Before the PET scan, T1-weighted magnetic resonance (MR)
images (Turbo Field Echo [TFE] SENSE protocol; Act. TR  8.9 ms,
TE 4.6ms, 192 TFE shots, TFE duration 1201.9 s, FOV 256 256
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mm, voxel size 1 1 1 mm) were acquired on a 3T Intera Achieva
whole-body scanner (Philips Healthcare).
PET imaging: [11C]FLB 457 data acquisition and preprocessing (Sample
3). [11C]FLB 457, 5-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-
3-methoxy-2-(methoxy-11C) benzamide was synthesized as previously
described (Sandiego et al., 2015) in the radiochemistry laboratory within
the Yale PET Center in the Yale School of Medicine. PET scans were
acquired on the high-resolution research tomograph (Siemens Medical
Solutions). [11C]FLB 457 (median specific activity: 7.80 mCi/nmol) was
injected intravenously as a bolus (315 MBq; average 8.62 mCi, SD
2.03 mCi) over 1 min by an automated infusion pump (Harvard Appa-
ratus). Before each scan, a 6 min transmission scan was performed for
attenuation correction.Dynamic scan datawere acquired in listmode for
90min following the administration of [11C]FLB 457 and reconstructed
into 27 frames (6  0.5 min, 3  1 min, 2  2 min, 16  5 min) with
corrections for attenuation, normalization, scatter, randoms, and dead
time using the MOLAR (Motion-compensation OSEM List-mode Algo-
rithm for Resolution-Recovery Reconstruction) algorithm (Carson et al.,
2004). Event-by-event, motion correction (Jin et al., 2013) was applied
using a Polaris Vicra optical tracking system (NDI Systems) that detects
motion using reflectors mounted on a cap worn by the subject through-
out the duration of the scan. Before the PET scan, T1-weighted MR
images (MPRAGE protocol; TR 2.4 s, TE 1.9 ms, FOV 256 256
mm, voxel size 1 1 1mm)were acquired on a 3TTrio whole-body
scanner (Siemens Medical Systems). After decay correction and attenu-
ation correction, PET scan frameswere corrected formotion using SPM8
(Friston et al., 1994) with the 20th dynamic image frame of the first series
serving as the reference image. The realigned PET frames were then
merged and reassociated with their acquisition timing info in PMOD’s
PVIEW module to create a single 4D file for use in PMOD’s PNEURO
tool for further analysis.
Binding potential calculation.We estimated D2 receptor availability as
binding potential (BPND) using the simplified reference tissue model
(SRTM) with the cerebellum as the reference region (Lammertsma and
Table 1. Summary of past reward discounting studies using PET imaginga
Reference Feature Tracer Index
Study
population (N) Effect ROI Reported effect size Fisher r to Z
Joutsa et al., 2015 Time 11Craclopride
D2-like receptor
k PG (12) 	 Ventral striatum r	0.700,
p 0.01
zr	0.867,
SE 0.333
HC (12) NS r	0.010,
p 0.98
zr	0.01,
SE 0.333
11Cracloprideb
D2-like receptor
PG (12) 	 r	0.890,
p
 0.001
zr	1.42,
SE 0.333
HC (12) NS r 0.150,
p 0.65
zr 0.151,
SE 0.333
18FFDOPA DA
synthesis
PD (17) 	 Caudate r 0.640,
p 0.005
zr 0.758,
SE 0.267
Ballard et al., 2015 Time 18Ffallypride
D2-like receptor
Ln(k) MA (27) 	 Whole striatum r	0.342,
p 0.041
zr	0.356,
SE 0.204
HC (27) NS
r	0.179,
p .185
zr	0.181,
SE 0.204
Oberlin et al., 2015 Time 11Craclopride
D2-like receptor
AUC NTS (10) 	 Ventral striatumd r 0.650,
p 0.042
zr	0.775,
SE 0.378
Social drinker/
HC (11) 	
r 0.611,
p 0.046
zr	0.711,
SE 0.354
Eisenstein et al., 2015 Time 11CNMB
D2-like receptor
AUC OB (23)  Whole striatum Partial r	0.560,
p 0.01
zr 0.633,
SE 0.224
HC (19) NS
Partial r 0.05,
p 0.85
zr	0.050,
SE 0.250
Probability OB (23) 
Partial r	0.480,
p 0.04
zr 0.523,
SE 0.224
HC (19) NS
Partial r 0.140,
p 0.62
zr	0.141,
SE 0.250
Smith et al., 2016 Time 18FFMT DA synthesis Proportion (sooner) HC (16) NSc Putamen
Spearman’s rho	0.513,
p 0.060
zr	0.567,
SE 0.277
Cho et al., 2015 Time 11CPHNO
D2-like receptor
Ln(k) HC (11)  Pallidum quadratic, r 20.74,
p
 0.01
NA
Crunelle et al., 2014 Time 123IFP-CITb
DA transporter
k ADHD (24) 	 Putamen r	0.536,
p 0.010
zr 0.599,
SE 0.218
Treadway et al., 2012 Effort 18Ffallyprideb
D2-like receptor
Proportion (high effort) HC (25) NS Caudate r 0.295,
p 0.152
zr	0.304,
SE 0.213
Present study Time
18Ffallypride
D2-like receptor Proportion (sooner) HC (109) NS Whole striatum
Partial r 0.027,
p 0.793
zr 0.027,
SE 0.097
Probability Proportion (high probability) HC (84) NS
Partial r	0.148,
p 0.230
zr	0.149,
SE 0.111
Effort Proportion (low effort) NS
Partial r	0.048,
p 0.700
zr	0.048,
SE 0.111
aThe effect sizes are shown as originally reported, but Fisher r-to-Z values have been sign-flippedwhen necessary to facilitate comparison of discountmeasures across studies (more positive values reflected greater discounting). HC, Healthy
control; MA,methamphetamine user; PG, pathological gambling; NTS, non–treatment-seeking alcoholism; OB, obesity; NS, non-significant;, increased discounting;	, decreased discounting;, inverted U effect frommPFC repetitive
transcranial magnetic stimulation.
bDA release.
cMedian split of FMT statistically significant.
dStatistic from reported peak voxelwise result.
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Hume, 1996) via two approaches: voxelwise and ROI-based (by fitting
time activity curves). PMOD’s PXMOD tool was used to estimate
BPND voxelwise using a published basis function fitting approach
(Gunn et al., 1997) (for average voxelwise BPND images from all three
samples, see Fig. 1).
The set of ROIs did not completely overlap across samples due to
differences in regional coverage of the radiotracers (Samples 1, 2, 3: mid-
brain, thalamus, amygdala, hippocampus, anterior cingulate cortex
[ACC], and insula; Samples 1 and 2: ventral striatum, caudate, putamen).
The midbrain was drawn in MNI standard space using previously de-
scribed guidelines (Mawlawi et al., 2001; Dang et al., 2012a,b) and regis-
tered to PET images using the same transformations used in BPND
calculation. All other ROIs were derived from the Hammers Atlas plus
deep nuclei parcellation as produced from the parcellation of the T1
structural image of each subject in the PNEUROmodule of PMOD soft-
ware. The PET data were registered to the T1 image for each subject and,
thus, to the ROIs (all steps implemented in PNEUROmodule of PMOD
software). BPND values from ROIs were obtained by fitting the SRTM to
the PET time activity curve data from each ROI in the PKIN (kinetic
modeling) module of PMOD using the cerebellum as the reference re-
gion. These ROI-based BPND values were then averaged across hemi-
spheres. Recently, our laboratory and others have shown thatmany brain
regions may be susceptible to partial volume effects in estimating BPND,
especially in older adults as a result of age differences in gray matter
volume (Smith et al., 2017). PVC increased estimated binding potential
across adults of all ages while also increasing individual differences not
related to age (Smith et al., 2017). Therefore, we used PVC values in all
analyses presented here, with the exception of themidbrain for which we
used uncorrected BPND for analysis, because it was not available in the
Hammers Atlas in PNEURO.We shared both corrected and uncorrected
values for all ROIs if others want to do additional analysis (these data can
be accessed at https://osf.io/htq56/).
We extracted mean D2-like BPND from the midbrain (mean  SD:
1.39 0.356) for all samples because both [18F]fallypride and [11C]FLB
457 have demonstrated good SNR in this region (Ray et al., 2012; Nar-
endran et al., 2014).We extractedmean striatal D2-like BPND from Sam-
ples 1 and 2 in the ventral striatum (uncorrectedmean SD: 18.6 3.30;
PVC mean  SD: 37.6  8.43), caudate (uncorrected mean  SD:
16.18 3.52; PVCmean SD: 26.1 5.54), and putamen (uncorrected
mean  SD: 22.8  3.40; PVC mean  SD: 33.0  5.03). Because
[11C]FLB 457 has poor SNR in the striatum compared with [18F]fally-
pride, we did not extract striatal BPND from Sample 3. We extracted
mean D2-like BPND from all samples in the ACC (uncorrected mean
SD: 0.732 0.281; PVC mean SD: 0.912 0.385), thalamus (uncor-
rected mean  SD: 2.32  0.622; PVC mean  SD: 2.74  0.638),
amygdala (uncorrected mean  SD: 2.191  0.490; PVC mean  SD:
Table 2. Study demographics and decision preference descriptive statisticsa
Sample 1 Sample 2 Sample 3 Significance
Tracer 18Ffallypride 18Ffallypride 11CFLB 457
N 25 84 35 —
Age 20.9 1.83 49.4 17.6 47.7 17.4 F(2,141) 31.8, p
 0.001
Sex 13 F, 12 M 48 F, 36 M 20 F, 15 M 2 (2, N 144) 0.22, p 0.896
Years of education 14.8 1.35 16.1 1.97 16.5 2.54 F(2,132) 5.49, p 0.005
Household income — $60K-69K $50K-$59K F(1,116) 3.70, p 0.057
Proportion (sooner) 0.550 0.230 0.452 0.243 0.497 0.258 F(2,140) 1.67, p 0.191
Ln(k 1) time 0.013 0.013 0.011 0.013 0.014 0.013 F(2,140) 0.990, p 0.376
Proportion (high probability) — 0.681 0.168 0.678 0.181 F(1,117) 0.009, p 0.925
Ln(k 1) probability — 1.18 0.557 1.23 0.664 F(1,117) 0.127, p 0.722
Proportion (low effort) — 0.131 0.165 — —
Ln(k 1) effort — 0.399 0.517 — —
Midbrain BPND 1.53 0.242 1.20 0.211 1.73 0.407 F(2,141) 48.5, p
 0.001
Caudate BPND 27.5 5.27 25.7 5.58 — F(1,107) 2.03, p 0.157
Putamen BPND 34.1 4.77 32.7 5.09 — F(1,107) 1.48, p 0.226
Ventral striatum BPND 32.1 8.82 39.2 7.64 — F(1,107) 15.4, p
 0.001
ACC BPND 1.08 0.433 0.743 0.262 1.20 0.381 F(2,141) 27.9, p
 0.001
Thalamus BPND 2.63 0.357 2.45 0.409 3.50 0.625 F(2,141) 64.9, p
 0.001
Amygdala BPND 2.87 0.579 3.18 0.666 3.08 0.798 F(2,141) 1.95, p 0.146
Hippocampus BPND 1.45 0.703 1.51 0.500 1.13 0.436 F(2,141) 6.47, p 0.002
Insula BPND 2.84 0.465 2.41 0.719 1.86 0.548 F(2,141) 17.7, p
 0.001
aThe difference in years of education between samples is due to Sample 1 being composed almost entirely of current college students who had not yet completed their education.
5+Cortical BPND
Striatal BPND 25+0
0
A B C
Figure 1. Average DA D2R availability. Average voxelwise whole-brain binding potential for (A) Sample 1 collected using [18F]fallypride in young adults, (B) Sample 2 collected using
[18F]fallypride across the adult life span, and (C) Sample 3 collected using [11C]FLB 457 across the adult life span. Sagittal images use the cortical BPND color scale. Axial images use the striatal BPND
color scale. The differences in binding potential between cortical and striatal regions depend on the radiotracer and mean age of the sample.
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3.10  0.692), hippocampus (uncorrected mean  SD: 1.05  0.308;
PVC mean  SD: 1.40  0.546), and insula (uncorrected mean  SD:
2.12 0.654; PVCmean SD: 2.35 0.714). To avoid arbitrary delin-
eations of larger cortical regions, cortical BPND associations were evalu-
ated with whole-brain voxelwise analyses (discussed in Experimental
design and statistical analysis).
Approval for the [18F]fallypride study protocol (Samples 1 and 2) was
obtained from the Vanderbilt University Human Research Protection
Program and the Radioactive Drug Research Committee. Approval for
the [11C]FLB 457 study protocol (Sample 3) was obtained from the Yale
University Human Investigation Committee and the Yale-New Haven
Hospital Radiation Safety Committee. All participants in each sample
completed written informed consent. Each samples’ study procedures
were approved in accordance with the Declaration of Helsinki’s guide-
lines for the ethical treatment of human participants.
Reward discounting tasks. All samples completed a temporal discount-
ing task (N  144), Samples 2 and 3 also completed a probability dis-
counting task (N 119), and Sample 2 also completed a physical effort
discounting task (N  84). All tasks were incentive-compatible (played
for real cash earnings) and performed during fMRI scanning (Samples 1
and 2) or on a computer in a behavioral laboratory (Sample 3) on a
separate visit from the PET imaging session as part of larger multimodal
neuroimaging studies. The average number of days between a PET im-
aging session and performance on discounting tasks was similar between
studies (Sample 1: 18.2 12.5; Sample 2: 25.0 18.4; Sample 3: 38.9
27.3).
Temporal discounting task. All three samples completed a temporal
discounting task adapted from a previously used paradigm (McClure et
al., 2004). On each trial, participants chose between an early monetary
reward and a late reward. In Sample 1, the delay of the early reward was
set to today, 2 weeks, or 1month, whereas the delay of the late rewardwas
set to 2 weeks, 1 month, or 6 weeks. In Samples 2 and 3, the delay of the
early reward was set to today, 2 months, or 4 months, whereas the delay
of the late reward was set to 2 months, 4 months, or 6 months. In all
samples, the early reward magnitude ranged between 1% and 50% less
than the late reward. Participants in Sample 1 played 84 (42 trials in two
runs) trials of the temporal discounting task and participants in Samples
2 and 3 played 82 trials (41 trials in two runs). One participant in Sample
3 had missing data for this task, producing a total sample size of 143
participants with temporal discounting data across all samples.
Probabilistic discounting task. Samples 2 and 3 completed a probabilis-
tic decision-making task similar to commonly used two-alternative
forced choice mixed gamble tasks (Levy and Glimcher, 2011). On each
trial, participants chose between a smallermonetary rewardwith a higher
probability and a larger reward with a lower probability. The probability
of the higher probability reward was set to 50%, 75%, or 100%, whereas
the probability of the lower probability reward was set to 25% or 50%
lower. The higher probability rewardmagnitude ranged between 1% and
50% lower compared with the lower probability reward. Participants in
Samples 2 and 3 played 82 trials of the probability discounting task. Data
for this task were available for all participants, producing a total sample
size of 119 participants with probability discounting data.
Effort discounting task. The Effort Expenditure for Rewards Task
(EEfRT)was adapted froman existing paradigm that used finger pressing
as the physical effort required for earning a reward (Treadway et al.,
2009). On each trial, participants chose between a smaller monetary
reward available for a lower amount of physical effort (pinky finger but-
ton presses) and a larger reward available for a higher amount of effort.
The effort required for the smaller reward was set as 35%, 55%, or 75%
(of each participant’s maximum press rate), whereas the effort required
for the larger reward was set as 20% or 40% higher than the smaller
reward (i.e., 55%, 75%, or 95%). The number of button presses required
for each level of effort was individually determined based on an initial
calibration procedure in which participants pressed a button with their
pinky finger as many times and as rapidly as possible in a few short
intervals. The smaller magnitude reward ranged between 1% and 50%
lower than the larger reward. On half of the trials, after making a choice,
participants were shown a 1 s “Ready” screen and then completed the
button-pressing task. Participants in Sample 2 played 82 trials of the
effort discounting task. No participant had missing data for this task,
producing a total sample size of 84 participants with effort discounting
data.
Computational modeling of reward discounting. In addition to a simple
calculation of the proportion of smaller magnitude (less delayed/higher
probability/lower effort) reward choices, we used a computationalmodel
to estimate behavioral preferences. For each participant and each task,
discounting was modeled with a hyperbolic discounted value function,
SV 
R
1 kC
, where R represents the monetary reward magnitude, k
represents the discount rate, and C represents either: (1) proportion of
maximum finger press rate for effort, (2) odds against winning (1 	
p(win))/p(win)) for probability, or (3) delay in days for time. Data were
fit with a softmax as the slope of the decision function. Because k values
are not normally distributed, we used natural log-transformed values
Ln(k 1). Past work from our laboratory has shown k values and simple
proportion of smaller reward choices are highly correlated (Seaman et al.,
2018). We report both scores for transparency.
Experimental design and statistical analysis.TodeterminewhetherD2R
availability in the midbrain, striatum, and extrastriatal regions were as-
sociated with discounting, we combined one sample of healthy young
adults with two cross-sectional healthy adult life-span samples. We ran
linear regressions between BPND and the proportion of sooner/higher
probability/lower effort choices as well as k values. Regressions included
control variables for age, sex, and study sample (using dummy coded
variables for Samples 2 and 3 where appropriate). Standardized  coef-
ficients are reported for these primary analyses. We corrected for multi-
ple comparisons within each cost domain (time, probability, effort) for
each region available for each combination of samples because not all
samples were tested on all tasks or had BPND for all regions. We applied
Bonferroni correction to p values as follows: midbrain  0.05; striatal
ROIs  0.05/3  0.016; extrastriatal ROIs  0.05/5  0.010. Previous
work has documented associations between discounting and household
income and education (deWit et al., 2007; Reimers et al., 2009). Because
we did not identify such associations between education or income with
discounting in any task, we did not include these measures as covariates
in regressions.
Additional exploratory ROI analyses examined whether associations
between DA and discounting varied across age groups or study samples.
Full evaluation of these effects required running 27 additional multiple
regression analyses that evaluated main effects of D2R availability, sex,
age, and study sample (as above in the primary analyses) in addition to
interactions between age andD2R availability and study sample andD2R
availability. Given the lack of specific hypotheses for these exploratory
analyses, we applied a Bonferroni correction for multiple comparisons;
only interactions that were significant at p 
 0.00185 (i.e., 0.05/27 
0.00185) are reportedwith follow-upwithin-group tests. Interactions are
reported as unstandardized  coefficients. Full model outputs for all of
these analyses are available on Open Science Framework (OSF) (https://
osf.io/htq56/).
Exploratory voxelwise statistical testing of D2R availability was sepa-
rately performed for each discounting task in each sample in MNI stan-
dard space. Because [11C]FLB 457 was acquired on a high-resolution
scanner, which produced maps with lower local spatial correlation, we
spatially smoothed these BPND maps with a 5 mm FWHM Gaussian
kernel to increase spatial SNR (Christopher et al., 2014; Plave´n-Sigray et
al., 2017). Linear regressions examining the effect of proportion of soon-
er/higher probability/lower effort choices or Ln(k 1) values on voxel-
wise BPND with age and sex as covariates were performed using FSL
Randomize (version 2.9) within each sample. Threshold-free cluster en-
hancement (Smith and Nichols, 2009) was used to detect regions with
significant correlations across the whole brain with nonparametric per-
mutation tests (5000 permutations). Statistical maps were thresholded at
p
 0.05.
Study 2
To identify research studies of interest, a PubMed search for the follow-
ing terms (((dopamine) AND positron emission tomography) AND hu-
mans) AND (discounting OR impulsive choice) yielded 10 studies. Five
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of these studies included original analysis of the relationship between
preferences in a discounting task and a PETmeasure of DA function and
were included. An additional exhaustive search via Google Scholar iden-
tified three additional relevant and includable studies. Notably, six of the
studies in the meta-analysis used tracers that bind to D2Rs for baseline
receptor availability or DA release measures (Treadway et al., 2012; Bal-
lard et al., 2015; Cho et al., 2015; Eisenstein et al., 2015; Joutsa et al., 2015;
Oberlin et al., 2015), two used tracers that measure presynaptic DA up-
take (Joutsa et al., 2015; Smith et al., 2016), and one used a tracer that
binds to DA transporters (DATs) (Crunelle et al., 2014). The study mea-
suringDAT reportedmethylphenidate occupancy after drug administra-
tion. To obtain the DAT BPND measure, we sign-flipped the correlation
becauseDATBPND is inversely related tomethylphenidate occupancy. In
addition to the present study (Study 1), which examined time, probabil-
ity, and effort, one other study examined both time and probability dis-
counting (Eisenstein et al., 2015), another study examined effort-based
discounting (Treadway et al., 2012), and the remaining studies examined
only time discounting. One of these studies used SPECT rather than PET
andwas included. If correlation coefficients were not reported, t statistics
and degrees of freedom were used to generate correlation coefficients
using the formula r  t2/t2  DF (Rosenthal and Rosnow, 2008).
Because correlations are bound and can be skewed, they were Fisher r- to
Z-transformed before meta-analysis. In the case of one study (Treadway
et al., 2012), correlations between caudateD2RBPND and preferences for
effort were originally reported as threewithin-task correlations (by prob-
ability condition). To approximate the full task correlation, we used the
Fisher r to Z transformation for the three correlations and then averaged
these values. Depending on the decision preference index reported
(Ln(k), proportion smaller, area-under-the-curve, etc.), we sign-flipped
Z scores so that more positive values reflected greater discounting (e.g.,
less willing to choose a larger, delayed/uncertain/effortful reward). One
study did not assess or report linear correlations (Cho et al., 2015). A
summary of these studies is presented in Table 1.
Because our group previously reported little to no correlation between
time, probability, and effort discounting in Sample 2 (Seaman et al.,
2016), we limited the meta-analysis to time-discounting measures only.
Therefore, the meta-analysis included 7 studies with 14 correlation ef-
fects (including the effect of time discounting from the present study).
The goal of the meta-analysis was to identify generalizable patterns that
address the broader question of whether discounting is related to general
striatal DA function. Because prior reports indicated positive associa-
tionswithin individuals between tracer targets, for example,D2 receptors
and DAT (Volkow et al., 1998; Yang et al., 2004), D2 receptors and DA
synthesis capacity (Berry et al., 2018), D2 receptors and DA release
(Samanez-Larkin et al., 2013),DAT andDA synthesis capacity (Sun et al.,
2012), and DAT and DA release (Volkow et al., 2002), we included all
studies that reported a correlation with a striatal region. It should be
noted that indices of any one of these radiotracer targets alonemay not be
reflective of general DA function but contribute to, and interact within,
complex spatiotemporal circuits that impact dopaminergic synapses. If a
study reported multiple striatal regions, we used the reported t statistics
and p values to select only the region with the largest effect size. Because
this resulted in inconsistent ROIs (with 6 effects in the whole striatum, 6
in the ventral striatum, 2 in the caudate, and 2 in the putamen), we
compared the correlation between time discounting in the present study
with D2R availability in the whole striatum. BPND for the whole striatum
was calculated as a volume-weighted average of the caudate, putamen,
and ventral striatumPVCBPND values. Included effects from the present
study controlled for age, sex, and study sample. Replacing the whole
striatum value with the largest substriatal effect size value in our study
(ventral striatum) did not change the pattern of results.
Meta-analytic effects were derived using the metafor R package
(Viechtbauer, 2010) in JASP (version 0.8.5.1) using random effects with
restricted maximum likelihood (JASP Team, 2018) to help account for
between-study variance. An initial meta-analysis across all studies eval-
uated whether the common correlation (intercept) was significantly0
(p 
 0.05). Because the study samples included groups with psychopa-
thology and radiotracers that bind to different dopaminergic targets, we
ran additional meta-analytic models to evaluate whether effect sizes de-
pended on the interaction of these terms. We dummy-coded study pop-
ulations as either belonging to a group that is characterized by addiction,
healthy controls, or any other psychopathology or disease. We coded the
following as addiction: pathological gambling, methamphetamine users,
andnon–treatment-seeking alcoholism.Other psychopathology samples
included obesity, PD, and treatment-naive ADHD samples. Radiotracer
targets wereD2Rs, including baseline and releasemeasures, DA synthesis
capacity, or DAT. We used the Q statistic to test the null hypothesis that
the common true correlation is zero and I2 values to assess significance
due to variance explained by heterogeneity of the effects (Borenstein et
al., 2011). Model fit quality statistics are reported for the intercept model
and the interactionmodel, along with each of the interactionmain effect
terms alone.We evaluated publication bias and study precision asymme-
try with visual inspection of a funnel plot and Egger’s test (p
 0.05).
Results
Study 1
Discounting across studies
Average behavioral measures of time and probability discounting
did not differ between samples (time: F(2,140)  1.63, p  0.200;
probability: F(1,117)  0.009, p  0.925), facilitating our ability to
combine samples for analysis. Simple choice proportions (e.g.,
smaller-sooner/total number of choices) were highly correlated
with computationally estimated discount rates Ln(k  1) for time
(r(141) 0.829, p
 0.001), probability (r(117) 0.798, p
 0.001),
and effort (r(82) 0.830, p
 0.001). A previous publication docu-
mented a lack of associations between time, probability, and effort
discountingwithina subsetofSample2 (N75),with theexception
ofamodest significant correlationbetween timeandeffortdiscount-
ing using the proportion choice variable but not using the discount-
ing parameters from the hyperbolic models (Seaman et al., 2018).
Across the samples included here, we also observed a general lack of
associations between discounting across the tasks. Once again, the
only exceptions were significant correlations within Sample 2 be-
tween time and effort discounting using both the proportion choice
variables (r(82) 0.27, p 0.014) and, here, a significant correlation
between theproportion choice variable for timediscounting and the
discounting model parameter (Ln(k  1)) for effort discounting
(r(82) 0.27, p 0.012). However, any associations or lack of asso-
ciations with behavioral measures of effort discounting should be
viewed with caution given that most participants selected a high
proportion of larger/high-effort choices creating a ceiling effect that
restricted the range of values.
Age effects on discounting and D2R availability
Samples 2 and 3 included adults of all ages. Age was not reliably
associated with reward discounting of time (r(141)  0.049, p 
0.563), probability (r(117)	0.007, p 0.947), or effort (r(82)
0.116, p 0.293). Age was negatively correlated with BPND in the
midbrain (r(142)  	0.442, 95% CI [	0.565, 	0.300], p 

0.001), caudate (r(107)	0.409, 95% CI [	0.555,	0.240], p

0.001), putamen (r(107)  	0.350, 95% CI [	0.505, 	0.173],
p
 0.001), anterior cingulate (r(142)	0.316, 95%CI [	0.456,
	0.161], p 
 0.001), and insula (r(142)  	0.437, 95% CI
[	0.560, 	0.294], p 
 0.001) but not in the ventral striatum
(r(107) 0.083, 95% CI [	0.106,	0.267], p 0.389), amygdala
(r(142)	0.145, 95%CI [	0.301, 0.019], p 0.083), hippocam-
pus (r(142)  	0.130, 95% CI [	0.287, 0.034], p  0.121), or
thalamus (r(142)	0.125, 95% CI [	0.283, 0.039], p 0.136).
Correlations between age and discounting within Sample 2 were
previously reported (Seaman et al., 2018). Correlations between
age and BPND for Samples 2 and 3 were previously reported
(Dang et al., 2016; Smith et al., 2017).
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Discounting and D2R availability
We did not identify associations between D2-like BPND in the mid-
brain anddiscounting across Samples 1, 2, and 3 or the striatumand
discounting across Samples 1 and 2 (Table 3).We identified amod-
est positive correlation between probability discounting and D2R
availability in the hippocampus (Ln(k 1):  0.197, SE 0.110,
t(114) 2.06, p 0.042). However, the correlation did not survive
correction for multiple comparisons. No associations were identi-
fied between discounting and any of the other ROIs in the primary
analyses (Table 3; Fig. 2).
Exploratory evaluation of possible interactions between age and
D2R availability or study sample and D2R availability in predicting
discounting revealed four significant interactions after controlling
for multiple comparisons. The significant interactions revealed that
the association betweenD2R availability and effort discounting var-
ied across age in the midbrain (chose low effort: 	0.0195, p
0.00006, Ln(k 1):	0.0496, p 0.0015) and ventral striatum
(chose low effort:   	0.00005, p  0.0009, Ln(k  1):  
	0.002, p  0.0002). Follow-up analyses examined simple effects
within younger adults (ages 18–30), middle-aged adults (ages 31–
57), and older adults (ages 57–83) from a tertile split of ages. In the
midbrain, there was a negative association betweenD2R availability
anddiscountingwithin older adults (chose low effort: r(32)	0.50,
p 0.002, Ln(k 1): r(32)	0.46, p 0.006) but nonsignificant
Table 3. ROI analyses for D2-like receptor availability (PVC) showing standardized regression coefficients (after adjustment for control variables) and 95% CIsa
Time Probability Effort
Region Proportion (sooner) Ln(k 1) Proportion (high probability) Ln(k 1) Proportion (low effort) Ln(k 1)
Midbrain 	0.156 	0.281, 0.065 S1,2,3 	0.114 	0.011, 0.004 S1,2,3 0.100 	0.085, 0.178 S2,3 0.253 	0.033, 0.840 S2,3 	0.129 	0.297, 0.096 S2 	0.148 	0.982, 0.255 S2
Caudate 0.039 	0.007, 0.011 S1,2 0.047 	3.00 10	4, 4.68 10	4 S1,2 	0.050 	0.009, 0.006 S2 	0.012 	0.025, 0.023 S2 	0.064 	0.009, 0.005 S2 	0.191 	0.041, 0.005 S2
Putamen 0.034 	0.008, 0.011 S1,2 0.029 	3.52 10	4, 4.66 10	4 S1,2 	0.194 	0.014, 0.001 S2 	0.178 	0.044, 0.005 S2 	0.017 	0.008, 0.007 S2 	0.129 	0.038, 0.011 S2
Ventral striatum 	0.069 	0.008, 0.004 S1,2 	0.106 	3.71 10	4, 1.21 10	4 S1,2 	0.117 	0.007, 0.002 S2 	0.099 	0.023, 0.009 S2 0.020 	0.004, 0.005 S2 0.106 	0.008, 0.023 S2
ACC 	0.017 	0.140, 0.119 S1,2,3 	0.043 	0.007, 0.004 S1,2,3 1.24 10	4 	0.109, 0.109 S2,3 0.011 	0.349, 0.385 S2,3 0.070 	0.098, 0.187 S2 0.105 	0.240, 0.655 S2
Thalamus 	0.018 	0.110, 0.074 S1,2,3 	0.105 	0.006, 0.002 S1,2,3 	0.085 	0.090, 0.047 S2,3 0.157 	0.092, 0.364 S2,3 0.049 	0.074, 0.113 S2 	0.075 	0.389, 0.200 S2
Amygdala 	0.139 	0.112, 0.012 S1,2,3 	0.138 	0.005, 5.63 10	4 S1, S2,3 0.025 	0.040, 0.052 S2,3 0.172 	0.011, 0.298 S2,3 0.178 	0.012, 0.101 S2 0.172 	0.045, 0.312 S2
Hippocampus 	0.009 	0.082, 0.074 S1,2,3 	0.030 	0.004, 0.003 S1,2,3 0.108 	0.029, 0.102 S2,3 0.197 0.008, 0.446 S2,3 0.202 	0.006, 0.140 S2 0.164 	0.062, 0.403 S2
Insula 0.142 	0.019, 0.117 S1,2,3 0.082 	0.002, 0.004 S1,2,3 	0.114 	0.077, 0.023 S2,3 	0.008 	0.176, 0.163 S2,3 0.039 	0.046, 0.064 S2 0.026 	0.153, 0.192 S2
aS1, Sample 1; S2, Sample 2; S3, Sample 3.
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Figure 2. Correlations between reward discounting and D2R availability. Correlation plots represent associations between D2R availability (PVC) and proportion of smaller sooner/higher
probability/less effortful choices. Individual subject data points are depicted for time (turquoise), probability (pink), and effort (green). Solid lines indicate regression slopes for [18F]fallypride.
Dotted lines indicate regression slopes for [11C]FLB 457.
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associations in younger adults (chose low effort: r(13)  0.23, p 
0.41, Ln(k  1): r(13)  0.25, p  0.36) and middle-aged adults
(chose low effort: r(33) 0.27, p 0.12, Ln(k 1): r(33) 0.12, p
0.48). In the ventral striatum, there was a positive association be-
tween D2R availability and discounting within younger adults
(chose loweffort: r(13)0.67,p0.007, Ln(k1): r(13)0.76,p

0.001) but nonsignificant associations inmiddle-aged adults (chose
low effort: r(33) 0.10, p 0.57, Ln(k 1): r(33) 0.20, p 0.26),
and older adults (chose low effort: r(32) 0.18, p 0.31, Ln(k 1):
r(32)  	0.16, p  0.38). No age  D2R availability interactions
reached corrected levels of significance in any other ROI for effort
discounting and in any ROI for time and probability discounting.
No study sample by D2R availability interactions reached corrected
levels of significance in any ROI for any task. See OSF for complete
model output and figures (https://osf.io/htq56/).
Voxelwise analysis of binding potential maps did not reveal
any significant correlationswith discounting.Unthresholded sta-
tistical maps can be viewed/downloaded from NeuroVault
(https://neurovault.org/collections/ZPFBVXPK/).
Study 2
Meta-analysis: DA PET studies of reward discounting
An initialmeta-analysis across all studies of temporal discounting
did not identify a significant common correlation between dis-
counting and kinetic measure of DA function (Omnibus test of
model coefficients, Cochran’s Q 1.03, p 0.310, I2 84.7%;
intercept	0.167, SE 0.164, Z	1.02, Akaike information
criterion [AIC] 28.6).
Alternatively, a model that included the interaction between
psychopathology group and radiotracer target provided a better
fit than the common correlationmodel (without interaction terms)
and accounted for the heterogeneity of effects (Omnibus test of
model coefficients, Cochran’s Q  35.2, p 
 0.001, I2  37.15%,
AIC 19.8). Inspection of the coefficients suggested that psychopa-
thology alone had a greater impact on the model than radiotracer
target: Healthy,D2-receptor/intercept	0.088, SE 0.124, Z  	0.708,
p0.479,DA synthesis capacity	0.479, SE0.357,Z	1.34,p
0.180;DAT	0.034,SE0.410,Z	0.084,p0.933;Addiction
	0.676,SE0.215,Z	3.14,p0.002;OtherPsychopathology0.720,
SE0.317,Z2.27,p0.023;Other Psychopathology,DA synthesis capacity
0.605, SE 0.566,Z 1.07, p 0.285.
A follow-up model with the radiotracer target interaction
term alone provided a worse fit (Omnibus test of model coeffi-
cients, Cochran’s Q  2.59, p  0.273, I2  83.9%, AIC  28.4).
However, the follow-upmodelwith thepsychopathology termalone
provided the best model fit compared with all other meta-analysis
models (Omnibus test of model coefficients, Cochran’s Q  35.7,
p
 0.001, I2 31.8%, AIC 14.3). Again, inspection of the coef-
ficients suggested that psychopathology alone had a greater impact
on the model, regardless of radiotracer target: Healthy/intercept 
	0.138, SE 0.110,Z	1.26, p 0.207,Addiction	0.616, SE
0.202,Z	3.05, p 0.002,Other Psychopathology 0.793, SE 0.199,
Z3.99,p
 0.001. A forest plot of the psychopathologymodel is
provided in Figure 3. Plotted values indicate Pearson correlation
coefficients for display purposes only. Visual inspection of asym-
metry in a funnel plot of effects from the psychopathologymodel
(Fig. 2) and Egger’s test (Z	2.24, p 0.025) indicated some
potential publication bias associated with differences between
studies reporting effects in specific psychopathology groups. Eg-
ger’s test did not indicate the presence of publication bias in the
common correlationmodel (Z	1.80, p 0.072) or full inter-
action model (Z	1.56, p 0.119).
The nature of the psychopathology group effect was that
healthy individuals showed a nonsignificant, small, negative cor-
relation between DA and discounting, the addiction groups
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328 • J. Neurosci., January 9, 2019 • 39(2):321–332 Castrellon et al. • Dopamine and Discounting
showed a significant and stronger negative association, and the
other psychopathology groups showed a stronger positive asso-
ciation relative to healthy controls. To facilitate comparison of
group effects with past and future studies, we converted esti-
mated coefficient Z values back to Pearson correlation coeffi-
cients. The correlation for the healthy group was r  	0.137,
95% CI [	0.339, 0.076], the correlation for the addiction group
was r  	0.638, 95% CI [	0.796, 	0.399], and the correlation
for the other psychopathology group was r  0.575, 95% CI
[0.319, 0.753]. Including additional data from studies using effort
and probability discountingmeasures did not change the pattern
of results (for additional data and figures shared on OSF, see
https://osf.io/htq56/).
Discussion
Here, we examined whether time, probability, and effort dis-
counting of monetary rewards were related to individual differ-
ences in DA function in humans. We found that preferences for
shorter time delays, higher probability, and lower physical effort
were generally uncorrelated with DA D2R availability across
brain regions in healthy adults.
A meta-analysis comparing correlations between discounting
and striatal DA function failed to detect a correlation 0. Con-
sistent with Study 1, DA and discounting in healthy groups were
unrelated. However, there was heterogeneity dependent on psy-
chopathology, with addiction showing a strong negative relation-
ship to DA. Together, these findings suggest that individual
differences in D2Rs are not reliably associated with discounting
in healthy adults. Despite numerous past findings suggesting a
role for DA in reward discounting behavior, the present findings
raise questions about the specific role of D2Rs in discounting.
The difference in correlations between healthy adults and
clinical groups in the meta-analysis suggests that individual dif-
ferences may depend on alterations in striatal DA function. In
addictions, striatal D2R expression is diminished (Volkow et al.,
2009; however, for discussion of mixed findings in pathological
gambling potentially due to specific facets of the disorder, see
Potenza, 2013). This lowered striatal D2R expression may not be
compensated by other features of the DA system, such as synthe-
sis capacity, release, reuptake, or metabolism, which also become
dysregulated in addictions (Volkow et al., 2009). As a result, it is
possible that effects on temporal discounting emerge when the
system is dysregulated. Dysregulation in different features of the
DA system may contribute to nonlinear individual differences.
The inverted-U hypothesis, for example, has been invoked to
characterize individual difference associations between DA and
cognition (Vijayraghavan et al., 2007; Cools and D’Esposito,
2011). In this case, changes in D2Rsmay shift the relative balance
in extracellular DA binding with D1-like receptors. Studies have
proposed similar inverted-U associations between striatal DA
and trait-level sensation-seeking (Gjedde et al., 2010) or fMRI
reward signals (Dreher et al., 2008), and cortical DA and delay
discounting (Smith and Boettiger, 2012; Elton et al., 2017). The
present meta-analytic results revealed little to no association in
the healthy range and positive and negative correlations in psy-
chopathology associated with disrupted DA function. An
inverted-U relationship driven by dysregulation of striatal DA
may account for the differential associations between discount-
ing andD2Rs between healthy and clinical groups. Future studies
of individuals with a broad range of disruptions inDA are needed
to properly test this hypothesis.
Importantly, the measures of baseline D2R availability were
static and cannot describe temporal changes in DA signaling re-
lated to reward cues. Potentially, individual differences only
emerge as a result of temporal dynamics of DAmidbrain spiking
or DA release (which may also be affected by psychopathology).
For example, phasic changes in rodents’ striatal DA release vary
with discounting behavior (Moschak and Carelli, 2017) and sub-
jective value (Schelp et al., 2017). Phasic changes might better
explain individual differences in human reward discounting. For
example, value-related fMRI activation linked to the decision
process may better capture individual difference associations
with baseline DA.
The striking difference inmeta-analytic correlation effects be-
tween healthy controls and individuals with psychopathology
suggests that individual difference findings in clinical samples
cannot be reliably generalized to healthy controls, and vice versa.
Disruption of brain function as a result of addiction, ADHD,
obesity, and PD is not limited to a striatal DA abnormality and is
more widespread across systems. Alterations in the DA system
may interact with changes to broader neural systems. For exam-
ple, one model of addiction suggests multiple cognitive and mo-
tivational corticostriatal circuits interact and compensate for
disruptions in glutamatergic andGABAergic prefrontal signaling
(Volkow et al., 2011). Disruptions to these circuits may affect the
relationship between DA and discounting in addiction (MacKil-
lop et al., 2011). In the context of reward processing, DA release
in the striatum impacts cholinergic (Wang et al., 2006), glutama-
tergic, and GABAergic signaling (Alexander and Crutcher, 1990;
Karreman and Moghaddam, 1996). Changes in these other sys-
tems may moderate effects of D2Rs on discounting, although
future studies with direct measures of these system interactions
are needed to evaluate this possibility.
Two of the samples in our empirical analysis included age
ranges wider than most PET studies of DA. Although age was
negatively correlated with D2R availability, we did not observe
age-related associations with discounting in any task. Although
prior studies described age differences in discounting (Green et
al., 1999; Simon et al., 2010), the lack of an association in the
present study is consistent with a recent study of23,000 adults
which did not identify a correlation between age and time dis-
counting (Sanchez-Roige et al., 2018). Well-documented age-
related D2 receptor loss with no changes in discounting behavior
is complementary evidence that individual differences in dis-
counting are not likely to beD2-mediated in healthy adults. Con-
trolling formain effects of age did not substantially change any of
the results of the primary analyses, suggesting that overall the
broad age range of our samples did not account for the lack of
effects. However, exploratory analysis of age by D2R availability
interactions revealed that associations between D2R availability
and effort discounting varied across adulthood such that associ-
ations were more positive in younger adulthood (particularly in
the ventral striatum) andmore negative in older adulthood (par-
ticularly in the midbrain, where the signal primarily reflects au-
toreceptors). If replicated, this patternmight suggest that changes
in themesolimbicDA systemwith age have differential impact on
effort-based decision making. However, it should be noted that
these analyses are based on Sample 2 (the only sample that in-
cluded the effort task), so the within-group analyses of effects are
based on relatively few participants. Future research with larger
samples across adulthood are needed to better assess the reliabil-
ity of these effects.
There are several weaknesses of the present studies. Because
the finger-pressing requirement for the effort task was not very
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difficult for participants, additional studies that elicit broader
individual differences in preferences are needed to better evaluate
associations between D2 receptors and effort discounting.
In the empirical study, we included data from two radiotrac-
ers, which have different kinetic properties. Because of this, tracer
is confounded with other sample differences. However, in many
regions, only one tracer contributed data. Furthermore, in pri-
mary analyses, we included sample as a covariate and observed no
significant interactions between sample and D2R availability in
predicting discounting.
The meta-analysis included data from multiple studies using
tracers with complementary coverage, but our empirical study
was limited to D2Rs. Future studies may benefit from comparing
multiple measures in the same individuals, for example, D2Rs
and DAT, the latter of which have been more consistently asso-
ciated with altering discounting behavior (Wade et al., 2000; van
Gaalen et al., 2006; Koffarnus et al., 2011). Although the meta-
analysis included oneDAT, twoDA synthesis, and twoDA release
effects, radiotracer target did not impact the overall effects in the
present analyses, and importantly, analyses restricted to D2 re-
ceptors did not impact results. However, given the limited num-
ber of effects for most DA targets, it is difficult to systematically
evaluate potential variation across the DA system.
Although the meta-analysis included studies with subject
samples varying broadly in clinical status, there was often only
one effect per diagnostic group. Importantly, effects from the
other psychopathology group that included ADHD, obesity, and
PD should be interpreted with caution. Although these groups
are similar in that they are impacted by alterations in DA func-
tion, there are differences in how DA is dysregulated in each of
them (e.g., presynaptic synthesis capacity, DA reuptake, postsyn-
aptic receptor expression) (Madras et al., 2005; Benton and
Young, 2016; Kaasinen and Vahlberg, 2017). Grouping of addic-
tionsmight present issues with respect to illness duration because
alterations to DA can exhibit different immediate and long-term
changes with drug use (Volkow et al., 2009).
Our meta-analytic results were restricted to temporal
discounting, but they were not impacted by the inclusion of cor-
relations for probability and effort discounting tasks. Unfortu-
nately, there were too few of these different task associations to
properly evaluate potential differential effects. Further, the ab-
sence of a strong relationship between time, probability, and ef-
fort discounting in the empirical data complicates our ability to
generalize preferences across tasks. It is possible that the meta-
analytic effects observed for time discounting may be different if
a greater number of effects for probability and effort were ob-
served. For example, gamblers discount over time but exhibit
risk-insensitive preferences (Holt et al., 2003), suggesting that
probability and time discounting may be different in addiction.
Thus, to better characterize specific diagnostic groups affected by
alterations in DA function, more studies are needed to evaluate
associations with various forms of discounting.
The present findings indicated that individual differences in
D2R availability are not consistently correlated with trait-level
individual differences in reward discounting. Our combination
of a relatively large empirical study with a meta-analysis adds
confidence to the findings and avoids the common weakness of
human PET studies, especially individual difference studies, that
typically lack statistical power. Future studies specifying the rela-
tionship between baseline DA function, temporal dynamics of
DA release, and discounting will likely provide additional insight
into how dopaminergic control of signaling influences decision
preferences in healthy individuals.
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